Hollow spherical nanoparticulate aggregates as potential ultrasound contrast agent: Shell thickness characterization

Drug Development and Industrial Pharmacy

Volumn 35, Issue 10, 2009, Pages 1167-1179

  Hadinoto, Kunn ^a   Cheow, Wean Sin ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

Hollow aggregates; Nanoparticles; Shell thickness; Spray drying; Ultrasound contrast agent

Indexed keywords

ECHO CONTRAST MEDIUM; METHOXY(POLYETHYLENE GLYCOL)METHACRYLATE; MICROSPHERE; NANOPARTICLE; POLY(METHYL METHACRYLATE); SILICON DIOXIDE; UNCLASSIFIED DRUG;

ARTICLE; PARTICLE SIZE; PH MEASUREMENT; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; TRANSMISSION ELECTRON MICROSCOPY;

CHEMISTRY, PHARMACEUTICAL; CONTRAST MEDIA; HYDROGEN-ION CONCENTRATION; METHACRYLATES; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYMETHYL METHACRYLATE; SILICON DIOXIDE; ULTRASONOGRAPHY;

EID: 70350697829     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040902824845     Document Type: Article

References (25)

1. Klibanov AL. (1999). Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv Drug Deliv Rev, 37(1-3):139-157
2. Lindner JR. (2004). Microbubbles in medical imaging: Current applications and future directions. Nat Rev Drug Discov, 3(6):527-532
3. Klibanov AL. (2002). Ultrasound contrast agents: Development of the field and current status, Contrast Agents Ii. Top Curr Chem, 222:73-106.
4. Ferrara K, Pollard R, Borden M. (2007). Ultrasound microbubble contrast agents: Fundamentals and application to gene and drug delivery. Ann Rev Biomed Eng, 9:415-447
5. Krasovitski B, Kimmel E. (2006). Stability of an encapsulated bubble shell. Ultrasonics, 44(2):216-220
6. Landau LD, Lifshitz EM. (1976). Mechanics, 1. New York: Pergamon Press.
7. Raisinghani A, DeMaria AN. (2001). Physical principles of microbubble ultrasound contrast agents, Symposium on Contrast Echocardiography (CE), Newport, Rhode Island, 3J-7J.
8. Bjerknes K, Sontum PC, Smistad G, Agerkvist I. (1997). Preparation of polymeric microbubbles: Formulation studies and product characterisation. Int J Pharm, 158(2):129-136
9. El-Sherif DM, Wheatley MA. (2003). Development of a novel method for synthesis of a polymeric ultrasound contrast agent. J Biomed Mater Res Part A, 66A(2):347-355
10. Narayan P, Wheatley MA. (1999). Preparation and characterization of hollow microcapsules for use as ultrasound contrast agents. Polymer Eng Sci, 39(11):2242-2255
11. Straub JA, Chickering DE, Church CC, Shah B, Hanlon T, Bernstein H. (2005). Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography. J Control Release, 108(1):21-32.
12. Pisani E, et al. (2006). Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: Physical characterization. Langmuir, 22(9):4397-4402
13. Schmidt W, Roessling G. (2006). Novel manufacturing process of hollow polymer microspheres. Chem Eng Sci, 61(15):4973-4981
14. Hadinoto K, Zhu K, Tan R.B.H. (2007b). Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery. Int J Pharm, 341(1-2):195-206.
15. Rossi S, Waton G, Krafft MP. (2008). Small phospholipid-coated gas bubbles can last longer than larger ones. Chemphyschem, 9(14):1982-1985
16. Tsapis N, et al. (2005). Onset of buckling in drying droplets of colloidal suspensions. Phys Rev Letters, 94(1):018302(1-4).
17. Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. (1999). PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. J Control Release, 57(2):171-185
18. Edwards DA, Dunbar C. (2002). Bioengineering of therapeutic aerosols. Ann Rev Biomed Eng, 4:93-107.
19. Park PIP, Jonnalagadda S. (2006). Predictors of glass transition in the biodegradable polylactide and poly-lactide-co-glycolide polymers. J Appl Polymer Sci, 100(3):1983-1987
20. Hadinoto K, Phanapavudhikul P, Kewu Z, Tan RBH. (2007a). Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: Effects of phospholipids. Int J Pharm, 333(1-2):187-198
21. Chaubal MV, Popescu C. (2008). Conversion of nanosuspensions into dry powders by spray drying: A case study. Pharma Res, 25(10):2302-2308
22. Chiou H, Chan HK, Heng D, Prud'homme RK, Raper JA. (2008). A novel production method for inhalable cyclosporine A powders by confined liquid impinging jet precipitation. J Aero Sci, 39(6):500-509
23. Freitas C, Muller RH. (1998). Spray-drying of solid lipid nanoparticles SLN (TM). Eur J Pharm Biopharm, 46(2):145-151
24. Abdullah EC, Geldart D. (1999). The use of bulk density measurements as flowability indicators. Powder Technology, 102(2):151-165
25. Iskandar F, Gradon L, Okuyama, K. (2003). Control of the morphology of nanostructured particles prepared by the spray drying of a nanoparticle sol. J Coll Inter Sci, 265(2):296-303.